C3d and C4d deposition early after lung transplantation.

TitleC3d and C4d deposition early after lung transplantation.
Publication TypeJournal Article
Year of Publication2008
AuthorsWestall GP, Snell GI, McLean C, Kotsimbos T, Williams T, Magro C
JournalJ Heart Lung Transplant
Volume27
Issue7
Pagination722-8
Date Published2008 Jul
ISSN1557-3117
KeywordsAdolescent, Adult, Biopsy, Bronchiolitis Obliterans, Complement C3d, Complement C4b, Female, Graft Rejection, Humans, Lung, Lung Transplantation, Male, Middle Aged, Peptide Fragments, Retrospective Studies
Abstract

BACKGROUND: Complement staining as a predictor of antibody-mediated rejection (AMR) after lung transplantation continues to be debated.

METHODS: In a cohort of 33 lung transplant recipients (LTRs) we assessed early post-transplant (

RESULTS: Significant C3d and C4d staining (i.e., Grade >or=2 on more than one occasion) was observed in 20 and 11 LTRs, respectively. Complement staining was increased in LTRs with severe primary graft dysfunction or airway infection, but was not associated with acute cellular or chronic rejection, or with morphologic features of AMR. In a sub-group analysis we identified 9 LTRs who developed early bronchiolitis obliterans syndrome (BOS) in the absence of acute cellular rejection or cytomegalovirus reactivation, but they had significant lung allograft C3d/C4d deposition along with corroborative light-microscopic features suggestive of AMR.

CONCLUSIONS: Complement activation, as judged by lung allograft deposition of C3d/C4d, is common early post-lung transplant and may be triggered by primary graft dysfunction and/or airway infection, and may play a role in the development of early BOS.

DOI10.1016/j.healun.2008.03.018
Alternate JournalJ Heart Lung Transplant
PubMed ID18582800
Related Faculty: 
Cynthia M. Magro, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700